TalkMed CEO suspended for eight months
PROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
Share with us your feedback on BT's products and services
TRENDING NOW
Can a first-time homebuyer couple earning S$18,000 a month afford a new EC unit?
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Asia needs new energy security architecture
Chagee, Mixue and Luckin won the market. Sustaining their edge is the harder part
